Navigation Links
Endexx Secures Exclusive World Wide Rights for Medical Marijuana Dispensing Technology
Date:8/12/2013

CAVE CREEK, Ariz., Aug. 12, 2013 /PRNewswire/ -- Endexx Corporation OTC: EDXC. Endexx, through its wholly owned subsidiary, Dispense Labs LLC., has secured its "Supply Agreement" and its Intellectual Property "Licensing Agreement" with AutoCrib Inc. This agreement ensures International Exclusive rights for the Autospense™ tracking, inventory control, dispensing technology platform for the Marijuana and Cannabis industries. The AutoCrib 1000™, in Joint Collaboration between AutoCrib Inc. and Dispense Labs LLC. was specifically adapted and designed as a pharmaceutical grade dispense system for both the medical marijuana and recreational markets, as well as, edibles, concentrates, delivery systems, tobacco products, vaporizers, electronic cigarettes and other related products.  These agreements solidify a long term and secure business partnership between Endexx Corporation's, Dispense Labs LLC., and AutoCrib Inc.

The Autospense™ system provides the capability to dispense a wide variety of objects or packages. Depending on their size, Autospense™ can manage approximately 800- 1000 individual packaged items for dispensing. The system also accepts US currency, credit and debit cards, and stored value devices. Autospense™ provides a complete user interface platform allowing patients/customers to visually select their chosen items, by price, brand, use and quantity. A full photo library and descriptions of each item assists a patient/customer in purchasing exactly what they need or prefer through an interactive touch screen. The system also provides patient/member verification tools, i.e., biometric fingerprinting, providing protection for the dispensary, retail outlet or health clinic dispensing cannabis related products. Endexx, through Dispense Labs LLC., is now planning, designing and securing access to external technologies and services for a complete enterprise suite platform that enhances the seed to sale tracking, transaction, accountability and compliance solutions for the rapidly growing marijuana industry.

The Autospense™ solution can be implemented at every point in the supply chain of the marijuana plant: seed, grower, harvest, processing, testing, transportation, pain clinic, alternative medicine facilities, dispensing, inventory control, law enforcement, compliance, Doctors, caregivers, patient possession and the sale. This total solution technology protects the patient/customer and ensures a safe and compliant product. The technology provides a full compliance package for all handlers of the product from seed to sale. Through standardization, Endexx, Dispense Labs, and the M3Hub will foster and nurture a sustainable growth industry.         

About Endexx:

Endexx Corporation is a micro-cap publicly traded company, representing the interest of its shareholders and collaborating with independent software developers, scientists, engineers, and other companies to build businesses that can thrive collectively in the equity markets. Endexx's team recognizes that individually small companies with new technologies have an extremely difficult time sustaining themselves as stand-alone companies. Through our collaborative practices, individual and group skill sets are better utilized to develop technology and grow the business, while centralizing costs and eliminating redundancies.

The Endexx management team and its advisory group each have at minimum 10-50 years of experience in their respective fields. The business professionals associated with the direction of the company all have experience growing businesses, developing and implementing new technologies and running publicly traded corporations.

Endexx Corporation is ultimately structured to provide a platform for entrepreneurs to thrive, offering maximum return on investment through equity ownership in the parent corporation. Each individual is a shareholder and is encouraged and self-driven to be successful and contribute to the overall objective of increasing shareholder value.

About Dispense Labs

Dispense Labs LLC., has spent several years investing in the research, design and development, and beta testing of Autospense™, a one-of-a-kind technologically driven smart system that allows for the automated dispensing of medical marijuana along with precise inventory control, utilizing predictive analytic algorithm and tracking software.

Autospense™ is a uniquely designed, high-tech automated dispensing system that exceeds industry standards. The software used is specifically designed to properly control transactions and manage inventory. This will significantly improve profitability, accountability, security tracking and customer satisfaction.  The Autospense™ solution can easily be integrated with external software and service solutions as well, allowing for other market alliances and business partners to utilize this core technology to support other industry related ancillary services. The Autospense™ system is the only total technology solution in the medical marijuana industry today.   

Contact: Todd Davis at Todd.Davis@endexx.com   

Contact Endexx via email to receive corporate news and updates at Endexx@endexx.com

http://www.otcmarkets.com/stock/EDXC/quote, www.endexx.com, www.autospense.com

Safe Harbor Statement

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word "believe" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Endexx to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Endexx assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customer to pay for ordered products, and political and economic risks inherent in international trade.


'/>"/>
SOURCE Endexx Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Endexx identifies core platform for Medical Marijuana Industry
2. Endexx Acquires Medical Marijuana Management Technology
3. Endexx to attend NAMA Spring Expo for Medical Marijuana Technology Solutions
4. Endexx Enters Into Definitive Agreement to Acquire Dispense Labs, LLC
5. Endexx closes Acquisition of Dispense Labs LLC.
6. Delcath Systems, Inc. Secures $20 Million Credit Facility
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Benvenue Medical Secures $25 Million Series D Financing
9. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
10. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
11. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Homozygous Familial Hypercholesterolemia (HoFH) - ... Global Markets Direct,s latest Pharmaceutical and Healthcare ... – Pipeline Review, H2 2016, provides an ... (Metabolic Disorders) pipeline landscape. Homozygous familial ... caused due to mutation from both parents. ...
(Date:12/6/2016)... The pen needles market is projected to reach USD ... 2016, growing at a CAGR of 11.2% during the ... years, the pen needles market has witnessed various technological ... for safety injections in the healthcare industry. These advancements ... with an aim to reduce pain, increase comfort, and ...
(Date:12/6/2016)... 2016   AlloSource , one of the ... and soft-tissue allografts for use in surgical procedures, ... for being named to the Board of Examiners ... by the Commerce Department,s National Institute of Standards ... process excellence. The Baldrige Award is the nation,s ...
Breaking Medicine Technology:
(Date:12/7/2016)... Arizona (PRWEB) , ... December 07, 2016 , ... Delete® ... Just in Time For The Holiday Party Season. Save Up To 33% Off Botox® ... Laser Salon is providing the Phoenix Valley with Delightful Deals on Botox® ...
(Date:12/7/2016)... ... , ... The medical profession is well aware that heart attacks do indeed ... heart attacks among 138,602 people recorded a 35% higher number of heart attacks in ... of course–no time of year is a good time for a heart attack! In ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... medicine device WellnessPro Plus for consumers and healthcare professionals to manage chronic ... by expanding the treatment modalities available in a single device. The announcement ...
(Date:12/7/2016)... ... 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief but ... presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of published ... for this country. , Nancy attributes her patriotic nature to her WWII veteran father. ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):